Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19
Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19
傑富瑞維持對replimune集團的買入評級，將目標價格上調至19美元
Jefferies analyst Roger Song maintains Replimune Group (NASDAQ:REPL) with a Buy and raises the price target from $16 to $19.
傑富瑞分析師羅傑·宋維持對replimune集團（納斯達克：REPL）的買入評級，並將目標價從16美元上調至19美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。